142685-89-0 Usage
Uses
Used in Medicinal Chemistry:
(2S,3S)-3-(propylcarbaMoyl)oxirane-2-carboxylic acid is used as a building block for the synthesis of pharmaceutical compounds due to its unique structure and chiral properties, which can contribute to the development of new drugs with specific therapeutic effects.
Used in Drug Development:
In the pharmaceutical industry, (2S,3S)-3-(propylcarbaMoyl)oxirane-2-carboxylic acid is utilized as a key intermediate in the synthesis of complex molecules, potentially leading to the discovery of novel therapeutic agents with improved efficacy and selectivity.
Used in Chemical Biology Research:
As a research tool in chemical biology, (2S,3S)-3-(propylcarbaMoyl)oxirane-2-carboxylic acid aids in the investigation of biological processes and the development of probes for target identification and validation, furthering our understanding of disease mechanisms and the design of targeted therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 142685-89-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,2,6,8 and 5 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 142685-89:
(8*1)+(7*4)+(6*2)+(5*6)+(4*8)+(3*5)+(2*8)+(1*9)=150
150 % 10 = 0
So 142685-89-0 is a valid CAS Registry Number.
142685-89-0Relevant articles and documents
NOVEL DRUGS FOR DEMENTIA
-
Example 3, (2008/06/13)
The invention is directed to compounds that are prodrugs containing a chemical delivery system (CDS) moiety and a cysteine protease inhibitor moiety. The CDS moiety targets the prodrug to the brain or central nervous system. The cysteine protease inhibitor inhibits cysteine proteases upon release from the prodrug. Cysteine protease inhibitors are effective for treating dementia, Alzheimer's disease and vascular dementia. Targeting the brain or central nervous system offers significant advantages in treating these conditions and diseases. A preferred CDS prodrug is a dihydrotrigoneline CDS moiety coupled to an epoxysuccinyl peptide cysteine protease inhibitor moiety.
